Protection against lethal toxic shock by targeted disruption of the CD28 gene

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2675-2680

  Saha, Bhaskar ^a   Harlan, David M ^a   Lee, Kelvin P ^a   June, Carl H ^a   Abe, Ryo ^a,b  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; STAPHYLOCOCCUS TOXIN; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; BACTERIAL TOXINS; CROSSES, GENETIC; ENTEROTOXINS; FEMALE; HETEROZYGOTE; IMMUNITY, NATURAL; INTERFERON TYPE II; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029945194     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2675     Document Type: Article

References (32)

1. Chatila, T., P. Scholl, N. Ramesh, N. Trede, R. Fuleihan, T. Morio, and R.S. Geha. 1992. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-. Chem. Immunol. 55: 146-171.
2. Miethke, T., K. Duschek, C. Wahl, K. Heeg, and H. Wagner. 1993. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23:1494-1500.
3. Uchiyama, T., T. Tadakuma, K. Imanishi, M. Araake, S. Saito, X.J. Yan, H. Fujikawa, H. Igarashi, and N. Yamaura. 1989. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J. Immunol. 143: 3175-3182.
4. Choi, Y. J.A. Lafferty, J.R. Clements, J.K. Todd, E.W. Gelfand, J. Kappler, P. Marrack, and B.L. Kotzin. 1990. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172:981-984.
5. Norton, S.D., P.M. Schlievert, R.P. Novick, and M.K. Jenkins. 1990. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. J. Immunol. 144:2089-2095.
6. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science (Wash. DC). 248:705-711.
7. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
8. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
9. Boussiotis, V.A., J.G. Gribben, G.J. Freeman, and L.M. Nadler. 1994. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr. Opin. Immunol. 6:797-807.
10. Fraser, J.D., M.E. Newton, and A. Weiss. 1992. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J. Exp. Med. 175:1131-1134.
11. Goldbach Mansky, R., P.D. King, A.P. Taylor, and B. Dupont. 1992. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B. Int. Immunol. 4:1351-1360.
12. Green, J.M., L.A. Turka, C.H. June, and C.B. Thompson. 1992. CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferation. Cell Immunol. 145:11-20.
13. Ohnishi, H., T. Tanaka, J. Takahara, and M. Kotb. 1993. CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes. J. Immunol. 150:3207-3214.
14. Damle, N.K., K. Klussman, G. Leytze, and P.S. Linsley. 1993. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. J. Immunol. 150:726-735.
15. Rott, O., U. Tontsch, and B. Fleischer. 1993. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. J. Immunol. 150:87-95.
16. Muraille, E., T. De Smedt, J. Urbain, M. Moser, and O. Leo. 1995. B7.2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B. Eur. J. Immunol. 25: 2111-2114.
17. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson, and T.W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science (Wash. DC). 261: 609-612.
18. Lucas, P.J., I. Negishi, K. Nakayama, L.E. Fields, and D.Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757-5768.
19. Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569.
20. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
21. Harlan, D.M., R. Abe, K.P. Lee, and C.H. June. 1995. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin. Immunol. Immunopathol. 75:99-111.
22. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P.M. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-94.
23. Xu, H., J.A. Gonzalo, Y. St. Pierre, I.R. Williams, T.S. Kupper, R.S. Cotran, T.A. Springer, and J.C. Gutierrez-Ramos. 1994. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180:95-109.
24. Lindsten, T., C.H. June, J.A. Ledbetter, G. Stella, and C.B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (Wash. DC). 244:339-343.
25. Jongeneel, C.V., A.N. Shakhov, S.A. Nedospasov, and J.C. Cerottini. 1989. Molecular control of tissue-specific expression at the mouse TNF locus. Eur. J. Immunol. 19:549-552.
26. Beutler, B., and A. Cerami. 1989. The biology of cachectin/ TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7:625-655.
27. Gearing, A.J., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A.H. Davidson, A.H. Drummond, W.A. Galloway, R. Gilbert, and J.L. Gordon. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (Lond.) 370:555-557.
28. Mohler, K.M., P.R. Sleath, J.N. Fitzner, D.P. Cerretti, M. Alderson, S.S. Kerwar, D.S. Torrance, C. Otten-Evans, T. Greenstreet, and K. Weerawarna. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature (Lond.). 370:218-220.
29. Pimentel Muinos, F.X., M.A. Munoz Fernandez, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714-5722.
30. Steeg, P.S., R.N. Moore, H.M. Johnson, and J.J. Oppenheim. 1982. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J. Exp.Med. 156:1780-1793.
31. Matis, L.A., L.H. Glimcher, W.E. Paul, and R.H. Schwartz. 1983. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc. Natl. Acad. Sci. USA. 80:6019-6023.
32. Jongeneel, C.V., A.N. Shakhov, S.A. Nedospasov, J.C. Cerottini, K. Pfeffer, T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian et al. 1993. Molecular control of tissue-specific expression at the mouse TNF locus. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.